Goldman Sachs initiated coverage on several large-cap pharmaceutical companies, taking a cautious stance on Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), and AbbVie (NYSE:ABBV), while upgrading ...
42m
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback